The sudden appearance of the COVID-19 virus caused enormous disruptions in the business world. The smartest and most agile companies used data and analytics tools to quickly shift focus and stay afloat amid constantly changing conditions. Here are the stories of three companies that used data and insights to improve patient care, adapt to a tumultuous healthcare landscape, and maintain strong business operations.
Luma Health analyzes text data to improve healthcare messaging
Luma Health is a digital health insurance company that focuses on improving patient engagement and access to care. Their platform empowers healthcare practitioners with tools that make scheduling and collecting patient feedback simpler for all involved. When COVID-19 hit, the volume of healthcare data exploded; that explosion created challenges for medical professionals looking to make sense of a wide variety of data points pulled from new sources of information like patient texts. The data science teams at Luma Health used their analytics platform to identify trends in patient-provider communications and create effective new messaging for providers. This improved the patient experience and quality of care, all without raising Luma Health’s rates.
“In times of crisis, people need insight,” said Aditya Bansod, Luma Health Co-Founder and CTO. “The teams at Luma Health were able to use data analytics to analyze, recognize, and address the unpredictable swings in patient behavior that COVID-19 produced, harnessing insights to create a surge of innovation for good.”
G-Med saves lives through actionable insights
G-Med, the world’s largest online medical community featuring over one million verified physicians from around the globe, also faced unique challenges this year. G-Med is a repository for an enormous amount of data the pandemic has generated. An agile, customizable BI platform was needed to help G-Med aggregate and analyze their data and share the results transparently with the global medical community.
G-Med knew that pulling insights out of a vast pool of medical data would be a huge challenge, but also an opportunity. When the COVID-19 outbreak began, G-Med focused on improving the data analytics of its global forum to get actionable insights that would be applicable to healthcare patients worldwide. Some of the questions that were answered included the effectiveness of hydroxychloroquine in treating coronavirus and the use of mechanical ventilation in severe cases. The right business intelligence tool has the capacity to sift through these thousands of data points and surface insights on treatment protocols that can be easily accessed by users.
“In times of global crisis, innovative global solutions that are based on real-world practice data are needed,” says Ilan Ben Ezri, CEO of G-Med. “This is exactly what G-Med is doing. During COVID-19, we realized we had the ability to go even further with our crowdsourced data by accurately analyzing, creating new insights, and presenting the information in a way that was never done before.”
G-Med’s new app is called Medin’Sight and serves as a central repository for COVID-19-related medical information to feed answers and useful data to clinical researchers, as well as those fighting coronavirus on the front lines.
Glytec improves care and reduces hospital readmissions with analytics
Glytec specializes in helping simplify insulin therapy during hospital stays, improving patient care with customized glycemic management programs. Insights drawn from their substantial database of patient data are an essential part of how they help perform this life-saving service.
Using analytics, Glytec was able to track patient data in real time to understand how glycemic management affected outcomes for those hospitalized with COVID-19. Insulin-dependent patients faced additional challenges when battling the novel coronavirus, even before the frequency of blood glucose monitoring was reduced (both to limit exposure and because of PPE shortages). Hospitals struggled to safely reduce checks without endangering patients. Getting accurate data to caregivers in real time was key. Effectively collecting and analyzing data was critical for getting the best, life-saving recommendations in the hands of medical teams.
“The data is clear. While the shortage of PPE and frequent patient contact are a risk to healthcare establishments, appropriate glucose monitoring and management of insulin on an hourly basis is critical,” says Robby Booth, founder and SVP of Glytec
Building a healthier future
One year into the COVID-19 pandemic, we can see how successful companies handled the changing landscape and even emerged stronger on the other side. Innovative companies have put the lessons learned from their data and analytics into action to build a stronger foundation that will help them grow their businesses, and in some cases serve humanity, for years to come.